Busch Matthew C. bought AMGN
May 5, 2026 · Form 4 insider transaction
Busch Matthew C. bought 455 shares of Amgen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
455
Price
$0.00
Total value
N/A
InsiderBusch Matthew C.
Role—
CompanyAmgen Inc. (AMGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 5, 2026
Filing dateMay 7, 2026
Shares owned after4,435
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.